Home NDC 59262-368-11 Kids Pink Eye Relief
Product NDC 59262-368
Requested package NDC 59262-368-11
11-digit product format 592620368
Labeler code 59262
Product ID 59262-368_3d9a46ee-ff57-423a-a4b4-b9543045cbae
Type HUMAN OTC DRUG
Nonproprietary name ATROPA BELLADONNA, CALCIUM SULFIDE, EUPHRASIA STRICTA and PLATYCLADUS ORIENTALIS LEAF
Dosage form LIQUID
Route OPHTHALMIC
Labeler Similasan Corporation
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2018-11-15
Marketing end 0000-00-00
Substance ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA; PLATYCLADUS ORIENTALIS LEAF
Active strength 6 [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 16 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…2021-12-27 23:28 UTC · source 2021-12-27 8dfbde2a14a4…c9ff85d89658…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59262-368-11 Kids Pink Eye Relief 10 mL in 1 BOTTLE, DROPPER LIQUID 10 2 59262-368-11 Kids Pink Eye Relief 1 in 1 CARTON LIQUID 1 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59262-368 KIDS PINK EYE RELIEF (ATROPA BELLADONNA, CALCIUM SULFIDE, EUPHRASIA STRICTA AND PLATYCLADUS ORIENTALIS LEAF) LIQUID [SIMILASAN CORPORATION] 2 Legacy NDC, 2 package rows 20220211_d57e2928-85b9-40f5-97b3-8b80f9dee603.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 59262-368-11 59262036811 1 BOTTLE, DROPPER in 1 CARTON (59262-368-11) > 10 mL in 1 BOTTLE, DROPPER 2018-11-15 0000-00-00 No No Current